4Dreifuss FE, I.age MM,Roger J, et al. Droposal for classification of epilepsies and epileptic syndromes [J ]. Epilepsia, 1985,26 (3) : 268.
5Gidal B, Spencer N, Maly M, et al. Valproate-mediated disturb ances of hemostasis: relationship with dose and plasma concentra tion[J]. Neurology, 1994,44 : 1418-1422.
6May RB, Sunder TR. Hematologic manifestation of long term val- proate therapy[J]. Epilepsia, 1993,34 (6) : 1099-1101.
7Verrotti A, Greco R, Matera V,et al. Platelet count and function in children receiving sodium valproate[J]. Pediatr Neurol, 1999, 21:611-614.
8Dreifuss FE,Santilli N, Langer DH et al. Valproic acid hepatic fatalities:A retrospective review[J]. Neurology, 1987,37:379-85.
9Dreifuss FE, Langer DH, Moline KA et al. Valproic acid hepatic fatalities. Ⅱ. U.S. experience since 1984[J]. Neurology, 1989, 39:201-7.
10Bryant AE,Dreifuss FE. Valproic acid hepatic fatalities. Ⅲ. U.S. experience since 1986[J]. Neurology, 1996,46(2): 465-9.
